antibiotic resistance
Pattern Bioscience Wins BARDA Contract Worth up to $40.9M
The contract's base award is $22.5 million, which Pattern said will support the late-stage development of its single-cell microbiology ID and AST system.
Next Gen Diagnostics, Shionogi Collaborate on Sequencing-Based Antibiotic Susceptibility Analysis
NGD will use its computational platform to analyze whole-genome sequencing data to determine microbial antibiotic susceptibility to cefiderocol.
Diasorin Submits Gram-Negative Bacteria Panel for FDA 510(k) Clearance
The firm's Gram-negative blood culture assay is used to identify bacterial pathogens and drug resistances, with results within two hours of a Gram stain.
Human Microbiome Analysis Reveals Peptide Antibiotic Candidates
Researchers computationally analyzed human microbiome metagenomic datasets to identify peptides or proteins with activity against pathogenic bacteria.
CARB-X Awards $1M Each to Prompt Diagnostics, Fuse Diagnostics for Point-of-Care STI Tests
The funds will support the development of Prompt's test for drug resistant Neisseria gonorrhoeae and Fuse's test for N. gonorrhoeae and Chlamydia trachomatis.